PARP14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.731800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.436600E-01
Normal-vs-Stage2
4.986000E-01
Normal-vs-Stage3
3.625600E-01
Normal-vs-Stage4
3.487800E-01
Stage1-vs-Stage2
5.264600E-01
Stage1-vs-Stage3
3.471200E-01
Stage1-vs-Stage4
8.465200E-01
Stage2-vs-Stage3
1.701440E-01
Stage2-vs-Stage4
7.466200E-01
Stage3-vs-Stage4
3.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.713800E-01
Normal-vs-AfricanAmerican
4.540000E-01
Normal-vs-Asian
4.716400E-01
Caucasian-vs-AfricanAmerican
8.111800E-01
Caucasian-vs-Asian
9.771400E-01
AfricanAmerican-vs-Asian
8.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.654200E-01
Normal-vs-Female
4.819200E-01
Male-vs-Female
6.312800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.807800E-01
Normal-vs-Age(41-60Yrs)
5.105400E-01
Normal-vs-Age(61-80Yrs)
4.614800E-01
Normal-vs-Age(81-100Yrs)
4.246200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.024000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.317200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.456000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.045800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.398950E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.142400E-01
Normal-vs-Daily Drinker
4.776800E-01
Normal-vs-Weekly Drinker
2.061600E-01
Normal-vs-Occasional Drinker
4.459200E-01
Normal-vs-Social Drinker
5.766400E-01
Non Drinker-vs-Daily Drinker
2.092200E-01
Non Drinker-vs-Weekly Drinker
3.368000E-01
Non Drinker-vs-Occasional Drinker
5.140000E-01
Non Drinker-vs-Social Drinker
1.165810E-01
Daily Drinker-vs-Weekly Drinker
7.697000E-01
Daily Drinker-vs-Occasional Drinker
6.277800E-01
Daily Drinker-vs-Social Drinker
3.564800E-01
Weekly Drinker-vs-Occasional Drinker
5.607000E-01
Weekly Drinker-vs-Social Drinker
6.463200E-01
Occasional Drinker-vs-Social Drinker
2.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.800400E-01
Normal-vs-Grade 2
2.333700E-02
Normal-vs-Grade 3
5.382300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.369900E-04
Grade 1-vs-Grade 3
6.993300E-04
Grade 1-vs-Grade 4
2.800400E-01
Grade 2-vs-Grade 3
1.562840E-01
Grade 2-vs-Grade 4
2.333700E-02
Grade 3-vs-Grade 4
5.382300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.541600E-01
Normal-vs-NonDiabetic
4.599400E-01
Diabetic-vs-NonDiabetic
8.640200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.326200E-01
Normal-vs-NoPancreatitis
4.568000E-01
Pancreatitis-vs-NoPancreatitis
2.843600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.239800E-01
Normal-vs-N1
4.997200E-01
N0-vs-N1
3.613800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.702600E-01
Normal-vs-TP53-NonMutant
4.404800E-01
TP53-Mutant-vs-TP53-NonMutant
1.272300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
